Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Capecitabine
×
90 days
×
Clear all
Filters
3
NCT06469944
2026-03-16
MK-3475-06C
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
160 enrolled
NCT06312176
2026-03-13
MK-2870-010
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,200 enrolled
NCT04895358
2026-03-11
KEYNOTE-B49
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
340 enrolled
NCT03221426
2026-03-09
KEYNOTE-585
Merck Sharp & Dohme LLC
Phase 3
Completed
1,007 enrolled
25 charts
NCT05152147
2026-02-27
HERIZON-GEA-01
Jazz Pharmaceuticals
Phase 3
Active not recruiting
920 enrolled